| [1] |
Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). a clinicopathologic study of 41 cases[J]. Am J Clin Pathol, 1978, 69(6):573-580.
|
| [2] |
Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases[J]. Am J Clin Pathol, 1978, 69(3):289-298.
|
| [3] |
Balcom JH 4th, Rattner DW, Warshaw AL, et al. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization[J]. Arch Surg, 2001, 136(4):391-398.
|
| [4] |
Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts[J]. Gastroenterology, 148(4):824-848.
|
| [5] |
Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration[J]. J Gastrointest Surg, 2004, 8(8):935-950.
|
| [6] |
Wasif N, Bentrem DJ, Farrell JJ, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes[J]. Cancer, 2010, 116(14):3369-3377.
|
| [7] |
Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas[J]. Pancreatology, 2006, 6(1/2):17-32.
|
| [8] |
Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas[J]. Pancreatology, 2012, 12(3):183-197.
|
| [9] |
Bassi C, Salvia R, Molinari E, et al. Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa?[J]. World J Surg, 2003, 27(3):319-323.
|
| [10] |
Malleo G, Bassi C, Rossini R, et al. Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment[J]. Gut, 2012, 61(5):746-751.
|
| [11] |
Goh BK, Tan YM, Chung YF, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients[J]. World J Surg, 2006, 30(12):2236-2245.
|
| [12] |
Park JW, Jang JY, Kang MJ, et al. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients?[J]. Pancreatology, 2014, 14(2):131-136.
|
| [13] |
Sarr MG, Kendrick ML, Nagorney DM, et al. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms[J]. Surg Clin North Am, 2001, 81(3):497-509.
|
| [14] |
Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients[J]. Ann Surg, 2008, 247(4):571-579.
|
| [15] |
Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer[J]. Clin Gastroenterol Hepatol, 2004, 2(11):1026-1031.
|
| [16] |
Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors[J]. Am J Surg Pathol, 1999, 23(4):410-422.
|
| [17] |
Tanaka M, Kobayashi K, Mizumoto K, et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas[J]. J Gastroenterol, 2005, 40(7):669-675.
|
| [18] |
Christensen JA, Fletcher JG, Fidler JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection[J]. AJR Am J Roentgenol, 2004, 183(5):1367-1374.
|
| [19] |
Salvia R, Fernández-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection[J]. Ann Surg, 2004, 239(5):678-685.
|
| [20] |
Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution[J]. Langenbecks Arch Surg, 2012, 397(1):93-102.
|
| [21] |
Sato N, Fukushima N, Maitra A, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas[J]. Am J Pathol, 2004, 164(3):903-914.
|
| [22] |
Handra-Luca A, Couvelard A, Degott C, et al. Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas[J]. Virchows Arch, 2004, 444(3):235-238.
|
| [23] |
Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN[J]. Pancreas, 2011, 40(4):571-580.
|
| [24] |
Weinberg BM, Spiegel BM, Tomlinson JS, et al. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms[J]. Gastroenterology, 2010, 138(2):531-540.
|
| [25] |
D'Angelica M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome[J]. Ann Surg, 2004, 239(3):400-408.
|
| [26] |
Terris B, Cavard C. Diagnosis and molecular aspects of solid-pseudopapillary neoplasms of the pancreas[J]. Semin Diagn Pathol, 2014, 31(6):484-490.
|
| [27] |
Ud Din N, Arshad H, Ahmad Z. Solid pseudopapilllary neoplasm of the pancreas. a clinicopathologic study of 25 cases from Pakistan and review of Literature[J]. Ann Diagn Pathol, 2014, 18(6):358-362.
|
| [28] |
Kurokawa S, Hirabayashi K, Hadano A, et al. Do Solid Pseudopapillary Neoplasms Shrink After Menopause?: review of the Literature[J]. Pancreas, 2015, 44(6):998-999.
|
| [29] |
Visser BC, Yeh BM, Qayyum A, et al. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI[J]. AJR Am J Roentgenol, 2007, 189(3):648-656.
|